Yang Heng, Aprecio Raydolfo M, Zhou Xiaodong, Wang Qi, Zhang Wu, Ding Yi, Li Yiming
State Key Laboratory of Oral Diseases, Sichuan University, Chengdu, Sichuan, China.
Center for Dental Research, Loma Linda University School of Dentistry, Loma Linda, California, United States of America.
PLoS One. 2014 Jun 30;9(6):e100285. doi: 10.1371/journal.pone.0100285. eCollection 2014.
We derived mesenchymal stem cells (MSCs) from rat induced pluripotent stem cells (iPSCs) and transduced them with tumor necrosis factor alpha-stimulated gene-6 (TSG-6), to test whether TSG-6 overexpression would boost the therapeutic effects of iPSC-derived MSCs in experimental periodontitis.
A total of 30 female Sprague-Dawley (SD) rats were randomly divided into four groups: healthy control group (Group-N, n = 5), untreated periodontitis group (Group-P, n = 5), iPS-MSCs-treated and iPSC-MSCs/TSG-6-treated periodontitis groups (Group-P1 and P2, n = 10 per group). Experimental periodontitis was established by ligature and infection with Porphyromonas gingivalis around the maxillae first molar bilaterally. MSC-like cells were generated from rat iPSCs, and transducted with TSG-6. iPSC-MSCs or iPSC-MSCs/TSG-6 were administrated to rats in Group-P1 or P2 intravenously and topically, once a week for three weeks. Blood samples were obtained one week post-injection for the analysis of serum pro-inflammatory cytokines. All animals were killed 3 months post-treatment; maxillae were then dissected for histological analysis, tartrate-resistant acid phosphatase (TRAP) staining, and morphological analysis of alveolar bone loss.
Administration of iPSC-MSC/TSG-6 significantly decreased serum levels of IL-1β and TNF-α in the Group-P2 rats (65.78 pg/ml and 0.56 pg/ml) compared with those in Group-P (168.31 pg/ml and 1.15 pg/ml respectively) (p<0.05). Both alveolar bone loss and the number of TRAP-positive osteoclasts showed a significant decrease in rats that received iPSC-MSC/TSG-6 treatment compared to untreated rats in Group-P (p<0.05).
We demonstrated that overexpression of TSG-6 in rat iPSC-derived MSCs were capable of decreasing inflammation in experimental periodontitis and inhibiting alveolar bone resorption. This may potentially serve as an alternative stem-cell-based approach in the treatment and regeneration of periodontal tissues.
我们从大鼠诱导多能干细胞(iPSC)中获得间充质干细胞(MSC),并用肿瘤坏死因子α刺激基因6(TSG-6)对其进行转导,以测试TSG-6过表达是否会增强iPSC来源的MSC对实验性牙周炎的治疗效果。
将30只雌性Sprague-Dawley(SD)大鼠随机分为四组:健康对照组(N组,n = 5)、未治疗的牙周炎组(P组,n = 5)、iPS-MSCs治疗组和iPSC-MSCs/TSG-6治疗的牙周炎组(P1组和P2组,每组n = 10)。通过双侧上颌第一磨牙周围结扎并感染牙龈卟啉单胞菌建立实验性牙周炎。从大鼠iPSC中生成MSC样细胞,并用TSG-6进行转导。将iPSC-MSCs或iPSC-MSCs/TSG-6通过静脉和局部给药于P1组或P2组大鼠,每周一次,共三周。注射后一周采集血样分析血清促炎细胞因子。治疗3个月后处死所有动物;然后解剖上颌骨进行组织学分析、抗酒石酸酸性磷酸酶(TRAP)染色以及牙槽骨吸收的形态学分析。
与P组大鼠(分别为168.31 pg/ml和1.15 pg/ml)相比,P2组大鼠接受iPSC-MSC/TSG-6治疗后血清IL-1β和TNF-α水平显著降低(分别为65.78 pg/ml和0.56 pg/ml)(p<0.05)。与P组未治疗的大鼠相比,接受iPSC-MSC/TSG-6治疗的大鼠牙槽骨吸收和TRAP阳性破骨细胞数量均显著减少(p<0.05)。
我们证明大鼠iPSC来源的MSC中TSG-6过表达能够减轻实验性牙周炎中的炎症并抑制牙槽骨吸收。这可能潜在地成为一种基于干细胞的牙周组织治疗和再生的替代方法。